Lilly Ending Trial For Experimental Arthritis Treatment | Medical Informer

Home

Home » Symptoms & Conditions » Arthritis » Lilly Ending Trial For Experimental Arthritis Treatment

Lilly Ending Trial For Experimental Arthritis Treatment

Posted on 19 December 2012. Tags: Arthritis, Ending, Experimental, Lilly, treatment, trial

Lilly Ending Trial For Experimental Arthritis Treatment
Indianapolis-based Eli Lilly and Co. (NYSE: LLY) is stopping a late-stage trial for a potential rheumatoid arthritis treatment. Lilly says the decision was not made out of safety concerns and the experimental drug is still involved in two other Phase 3 …

Full News here – Read more on Inside INdiana Business (press release)

Leave a Reply Cancel reply

Latest
Popular
Comments
Tags
Subscribe

New device claims to give asthma sufferers relief May 25, 2013
Boehringer Ingelheim's tiotropium shows promising results in patients with … May 25, 2013
Judge – Okolona Assistant Police Chief Ramona Robertson guilty of 3 … May 24, 2013
Adverse Reactions and Death Prompt Recall For Anemia Drug May 24, 2013
CAT Scan Guided Biopsy of a Lung Lesion – Medical Informer Video May 24, 2013

lasik November 2, 2011
CT scan (3/13) – Medical Informer Video November 12, 2011
Cosmetic Surgery Documentary – Ethnic Nose Job – Plastic Surgeon Beverly Hills – Medical Informer Video November 23, 2011
Aspirin Toner – Medical Informer Video November 29, 2011
Animation about diabetes and the body. – Medical Informer Video December 5, 2011